Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients
- 11 April 1997
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 203 (1) , 1-10
- https://doi.org/10.1016/s0022-1759(97)00020-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Serum acute phase reactants and prognosis in renal cell carcinomaCancer, 1995
- The Prognostic Significance of Immune Changes in Patients with Renal Cancer and Melanoma Treated with Interferon-α2bTumor Biology, 1995
- Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-γ production of lymphocytesCancer Immunology, Immunotherapy, 1992
- The Influence of Cryopreservation on Activity and Surface Markers of Lymphokine‐Activated Killer CellsVox Sanguinis, 1991
- Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytesTransfusion, 1988
- Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinomaImmunology Letters, 1988
- Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cellsInternational Journal of Cancer, 1986
- Defect in lectin-induce interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's DiseaseEuropean Journal of Cancer and Clinical Oncology, 1985
- Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's diseaseClinical Immunology and Immunopathology, 1985
- Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigenInternational Journal of Cancer, 1973